Vanguard Group Inc. Acquires 171,876 Shares of Masimo Corporation $MASI

Vanguard Group Inc. boosted its holdings in Masimo Corporation (NASDAQ:MASI) by 3.7% during the 3rd quarter, Holdings Channel reports. The firm owned 4,810,011 shares of the medical equipment provider’s stock after acquiring an additional 171,876 shares during the period. Vanguard Group Inc. owned approximately 0.09% of Masimo worth $709,717,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Westfield Capital Management Co. LP grew its position in Masimo by 75.9% during the second quarter. Westfield Capital Management Co. LP now owns 1,181,203 shares of the medical equipment provider’s stock valued at $198,702,000 after buying an additional 509,724 shares during the period. 4D Advisors LLC boosted its stake in Masimo by 50.0% in the second quarter. 4D Advisors LLC now owns 45,000 shares of the medical equipment provider’s stock valued at $7,570,000 after acquiring an additional 15,000 shares during the last quarter. ING Groep NV purchased a new position in Masimo in the third quarter valued at about $3,069,000. Massachusetts Financial Services Co. MA grew its position in shares of Masimo by 6.1% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 2,619,960 shares of the medical equipment provider’s stock valued at $386,575,000 after acquiring an additional 149,567 shares during the period. Finally, Geode Capital Management LLC grew its position in shares of Masimo by 6.2% during the 2nd quarter. Geode Capital Management LLC now owns 896,418 shares of the medical equipment provider’s stock valued at $150,817,000 after acquiring an additional 52,100 shares during the period. 85.96% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently commented on MASI. Bank of America assumed coverage on shares of Masimo in a report on Monday, November 17th. They issued a “neutral” rating and a $162.00 price target on the stock. Stifel Nicolaus set a $180.00 price target on Masimo in a research note on Tuesday, February 17th. Wells Fargo & Company cut Masimo from an “overweight” rating to an “equal weight” rating and lowered their price objective for the company from $190.00 to $180.00 in a research note on Wednesday, February 18th. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a research report on Monday, December 1st. Finally, BTIG Research downgraded shares of Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. One analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Masimo presently has an average rating of “Hold” and a consensus price target of $181.17.

Masimo Stock Performance

NASDAQ:MASI opened at $175.25 on Tuesday. The business’s fifty day moving average is $139.89 and its 200 day moving average is $143.22. The firm has a market cap of $9.41 billion, a price-to-earnings ratio of -16.63, a PEG ratio of 1.77 and a beta of 1.26. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.92 and a current ratio of 2.84. Masimo Corporation has a 52-week low of $125.94 and a 52-week high of $194.88.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.